Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in California
INVESTOR NOTICE: Gemini Space Station (GEMI) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman
Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing
ALK announces successful outcome of phase 2 trial with its tablet for treatment of peanut allergy demonstrating early onset of efficacy
Novo Nordisk A/S – share repurchase programme
